Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Köpff
S. Köpff
University of Ulm
Lenalidomide
Multiple myeloma
Medicine
newly diagnosed
Pomalidomide
2
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
2017
Leukemia
Jan Krönke
Florian Kuchenbauer
Miriam Kull
Veronica Teleanu
L Bullinger
Donald Bunjes
Axel Greiner
S. Kolmus
S. Köpff
Martin Schreder
L.-O. Mügge
Christian Straka
Monika Engelhardt
Hartmut Döhner
Hermann Einsele
Florian Bassermann
Ralf Bargou
Stefan Knop
Christian Langer
Show All
Source
Cite
Save
Citations (29)
Influence of CRBN, IKZF1, and IKZF3 expression on outcome in lenalidomide treated newly diagnosed multiple myeloma patients
2015
Clinical Lymphoma, Myeloma & Leukemia
Jan Krönke
Florian Kuchenbauer
Miriam Kull
Veronica Teleanu
Lars Bullinger
A. Greiner
S. Kolmus
S. Köpff
L.-O. Mügge
Christian Straka
Florian Bassermann
Monika Engelhardt
Ralf C. Bargou
H. Einsele
Christian Langer
Stefan Knop
Show All
Source
Cite
Save
Citations (0)
1